A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)

Clinical trial NCT00282386 · COMPLETED

Trial details

NCT number: NCT00282386
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Adenoma

Start date: 1999-12-23
Primary completion: 2004-09-01
Enrollment: 2586

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.